Amphotericin B-resistant Aspergillus flavus infection successfully treated with caspofungin, a novel antifungal agent

被引:28
作者
Koss, T
Bagheri, B
Zeana, C
Romagnoli, MF
Grossman, ME
机构
[1] Columbia Presbyterian Med Ctr, Dept Dermatol, Oklahoma City, OK 73104 USA
[2] Columbia Presbyterian Med Ctr, Dept Med, Div Infect Dis, Oklahoma City, OK 73104 USA
关键词
D O I
10.1067/mjd.2002.120627
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Invasive aspergillosis is uncommon in immunocompetent hosts but is the second most common opportunistic fungal infection in immunocompromised patients. There has been a dramatic increase in the incidence of life-threatening aspergillosis during the past 2 decades, and the morbidity and mortality of these infections despite antifungal therapy remain unacceptably high. We describe a patient kith amphotericin B-resistant Aspergillus flavus successfully treated with caspofungin, an agent belonging to a new class of antifungal drugs. Caspofungin shows great promise in the treatment of invasive aspergillosis.
引用
收藏
页码:945 / 947
页数:3
相关论文
共 11 条
[1]   SYNTHESIS AND ANTIFUNGAL ACTIVITY OF NOVEL CATIONIC PNEUMOCANDIN B-O DERIVATIVES [J].
BOUFFARD, FA ;
ZAMBIAS, RA ;
DROPINSKI, JF ;
BALKOVEC, JM ;
HAMMOND, ML ;
ABRUZZO, GK ;
BARTIZAL, KF ;
MARRINAN, JA ;
KURTZ, MB ;
MCFADDEN, DC ;
NOLLSTADT, KH ;
POWLES, MA ;
SCHMATZ, DM .
JOURNAL OF MEDICINAL CHEMISTRY, 1994, 37 (02) :222-225
[2]   Echinocandins and pneumocandins - a new antifungal class with a novel mode of action [J].
Denning, DW .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1997, 40 (05) :611-614
[3]   Opportunistic infections in oncologic patients [J].
Emmanouilides, C ;
Glaspy, J .
HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 1996, 10 (04) :841-&
[4]  
GROSSMAN ME, 1995, CUTANEOUS MANIFESTAT
[5]   Cutaneous Aspergillosis [J].
Isaac, M .
DERMATOLOGIC CLINICS, 1996, 14 (01) :137-&
[6]   INCREASED ANTIFUNGAL ACTIVITY OF L-733,560, A WATER-SOLUBLE, SEMISYNTHETIC PNEUMOCANDIN, IS DUE TO ENHANCED INHIBITION OF CELL-WALL SYNTHESIS [J].
KURTZ, MB ;
DOUGLAS, C ;
MARRINAN, J ;
NOLLSTADT, K ;
ONISHI, J ;
DREIKORN, S ;
MILLIGAN, J ;
MANDALA, S ;
THOMPSON, J ;
BALKOVEC, JM ;
BOUFFARD, FA ;
DROPINSKI, JF ;
HAMMOND, ML ;
ZAMBIAS, RA ;
ABRUZZO, G ;
BARTIZAL, K ;
MCMANUS, OB ;
GARCIA, ML .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1994, 38 (12) :2750-2757
[7]   MORPHOLOGICAL EFFECTS OF LIPOPEPTIDES AGAINST ASPERGILLUS-FUMIGATUS CORRELATE WITH ACTIVITIES AGAINST (1,3)-BETA-D-GLUCAN SYNTHASE [J].
KURTZ, MB ;
HEATH, IB ;
MARRINAN, J ;
DREIKORN, S ;
ONISHI, J ;
DOUGLAS, C .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1994, 38 (07) :1480-1489
[8]   Infections in solid-organ transplant recipients [J].
Patel, R ;
Paya, CV .
CLINICAL MICROBIOLOGY REVIEWS, 1997, 10 (01) :86-+
[9]   OPPORTUNISTIC FUNGAL-INFECTIONS IN IMMUNOCOMPROMISED HOSTS [J].
RADENTZ, WH .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 1989, 20 (06) :989-1003
[10]   Clinical presentation of invasive aspergillosis [J].
Schwartz, S ;
Thiel, E .
MYCOSES, 1997, 40 :21-24